Association between serotonin transporter genotype, brain structure and adolescent-onset major depressive disorder: A longitudinal prospective study

Translational Psychiatry

Volumn 4, Issue 9, 2014, Pages

  Little, K ^a,b,c   Olsson, C A ^c,d   Whittle, S ^b,e   Youssef, G J ^a,f   Byrne, M L ^a   Simmons, J G ^a   Yucel M ^f   Foley, D L ^e   Allen, N B ^a,c,e,g  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g UNIVERSITY OF OREGON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN 5 HTTLPR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADOLESCENCE; ADOLESCENT; ADULT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BRAIN REGION; BRAIN SIZE; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROBIOLOGY; ORBITAL CORTEX; PHENOTYPE; PROSPECTIVE STUDY; RIGHT HEMISPHERE; RISK FACTOR; STRESS; BRAIN; BRAIN MAPPING; CHILD; GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; BRAIN MAPPING; CHILD; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 84926144371     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.85     Document Type: Article

References (100)

1. Canli T, Congdon E, Todd Constable R, Lesch KP. Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing. Biol Psychology 2008; 79: 118-125.
2. Congdon E, Lesch KP, Canli T. Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 27-32.
3. Meda SA, Stevens MC, Potenza MN, Pittman B, Gueorguieva R, Andrews MM et al. Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol 2009; 20: 390-399.
4. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. AM J Psychiatry 2001; 158: 1783-1793.
5. Fineberg NA, Chamberlain SR, Goudriaan AE, Stein DJ, Vanderschuren LJ, Gillan CM et al. New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spect 2014; 19: 69-89.
6. First MB. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J Nerv Ment Dis 2013; 201: 727-729.
7. Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Curr Opin Psychiatry 2007; 20: 255-261.
8. Verdejo-Garcia A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 2008; 32: 777-810.
9. Balestri M, Calati R, Serretti A, De Ronchi D. Genetic modulation of personality traits: a systematic review of the literature. Int Clin Psychopharmacol 2013; 29: 1-15.
10. Cservenka A, Nagel BJ. Risky decision-making: an FMRI study of youth at high risk for alcoholism. Alcohol Clin Exp Res 2012; 36: 604-615.
11. Dager AD, Anderson BM, Stevens MC, Pulido C, Rosen R, Jiantonio-Kelly RE et al. Influence of alcohol use and family history of alcoholism on neural response to alcohol cues in college drinkers. Alcohol Clin Exp Res 2013; 37: E161-E171.
12. Terracciano A, Esko T, Sutin AR, de Moor MH, Meirelles O, Zhu G et al. Metaanalysis of genome-wide association studies identifies common variants in CTNNA2 associated with excitement-seeking. Transl Psychiatry 2011; 1: e49.
13. Volkow ND, Wang GJ, Tomasi D, Baler RD. Obesity and addiction: neurobiological overlaps. Obes Rev 2013; 14: 2-18.
14. Bevilacqua L, Goldman D. Genetics of impulsive behaviour. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20120380.
15. Mann JJ. The serotonergic system in mood disorders and suicidal behaviour. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20120537.
16. Manco M, Dallapiccola B. Genetics of pediatric obesity. Pediatrics 2012; 130: 123-133.
17. Dalley JW, Roiser JP. Dopamine, serotonin and impulsivity. Neuroscience 2012; 215: 42-58.
18. Gorwood P, Le Strat Y, Ramoz N, Dubertret C, Moalic JM, Simonneau M. Genetics of dopamine receptors and drug addiction. Human Genet 2012; 131: 803-822.
19. Li D, He L. Meta-Analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry 2007; 12: 47-54.
20. Li D, Sham PC, Owen MJ, He L. Meta-Analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 2006; 15: 2276-2284.
21. Meda SA, Ruano G, Windemuth A, O'Neil K, Berwise C, Dunn SM et al. Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proc Natl Acad Sci USA. 2014; 111: E2066-E2075.
22. Liu J, Demirci O, Calhoun VD. A parallel independent component analysis approach to investigate genomic influence on brain function. IEEE Signal Process Lett 2008; 15: 413-416.
23. Meda SA, Narayanan B, Liu J, Perrone-Bizzozero NI, Stevens MC, Calhoun VD et al. A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort. NeuroImage. 2012; 60: 1608-1621.
24. Liu J, Pearlson G, Windemuth A, Ruano G, Perrone-Bizzozero NI, Calhoun V. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Hum Brain Mapp 2009; 30: 241-255.
25. Jupp B, Dalley JW. Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models. Br J Pharmacol 2014.
26. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003; 160: 1041-1052.
27. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, , Weiller E et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 4-57.
28. Frey MC, Detterman DK. Scholastic Assessment or g? The relationship between the Scholastic Assessment Test and general cognitive ability. Psychol Sci 2004; 15: 373-378.
29. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995; 51: 768-774.
30. Carver CS, White TL. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS scales. J Pers Soc Psychol 1994; 67: 319-333.
31. Torrubia R, Avila C, Molto J, Caseras X. The Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ) as a measure of Gray's anxiety and impulsivity dimensions. Pers Indiv Differ 2001; 31: 837-862.
32. Zuckerman M, Neeb M. Sensation seeking and psychopathology. Psychiatry Res 1979; 1: 255-264.
33. Sternberger LG, Burns GL. Obsessions and compulsions: psychometric properties of the Padua Inventory with an American college population. Behav Res Ther 1990; 28: 341-345.
34. Cherkil S, Satish S, Mathew SS, Dinesh N, Kumar CT, Lombardo LE et al. Crosscultural standardization of the South Texas Assessment of Neurocognition in India. Indian J Med Res 2012; 136: 280-288.
35. Hunt MK, Hopko DR, Bare R, Lejuez CW, Robinson EV. Construct validity of the Balloon Analog Risk Task (BART): associations with psychopathy and impulsivity. Assessment 2005; 12: 416-428.
36. Reynolds B, Schiffbauer R. Measuring state changes in human delay discounting: an experiential discounting task. Behav Process 2004; 67: 343-356.
37. Nunes AP, Oliveira IO, Santos BR, Millech C, Silva LP, Gonzalez DA et al. Quality of DNA extracted from saliva samples collected with the Oragene DNA selfcollection kit. BMC Med Res Method 2012; 12: 65.
38. Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc 2010; 5: 1564-1573.
39. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
40. Calhoun VD, Adali T, Pearlson GD, Pekar JJ. A method for making group inferences from functional MRI data using independent component analysis. Hum Brain Mapp 2001; 14: 140-151.
41. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM et al. A versatile gene-based test for genome-wide association studies. Am J Hum Genet 2010; 87: 139-145.
42. Reiner-Benaim A. FDR control by the BH procedure for two-sided correlated tests with implications to gene expression data analysis. Biom J 2007; 49: 107-126.
43. Dick DM, Smith G, Olausson P, Mitchell SH, Leeman RF, O'Malley SS et al. Understanding the construct of impulsivity and its relationship to alcohol use disorders. Addict Biol 2010; 15: 217-226.
44. Benson DL, Schnapp LM, Shapiro L, Huntley GW. Making memories stick: celladhesion molecules in synaptic plasticity. Trends Cell Biol 2000; 10: 473-482.
45. Gallistel CR, Tucci V, Nolan PM, Schachner M, Jakovcevski I, , Kheifets A et al. Cognitive assessment of mice strains heterozygous for cell-Adhesion genes reveals strain-specific alterations in timing. Philos Trans R Soc Lond Biol Sci 2014; 369: 20120464.
46. Corvin AP. Neuronal cell adhesion genes: key players in risk for schizophrenia, bipolar disorder and other neurodevelopmental brain disorders? Cell Adh Migr 2010; 4: 511-514.
47. Uhl GR. Molecular genetics of addiction vulnerability. NeuroRx 2006; 3: 295-301.
48. Yoo BK, Shim JC, Lee BD, Kim C, Chung YI, Park JM et al. Association of the neuronal cell adhesion molecule (NrCAM) gene variants with personality traits and addictive symptoms in methamphetamine use disorder. Psychiatry Invest 2012; 9: 400-407.
49. Schlaepfer DD, Mitra SK. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004; 14: 92-101.
50. Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophys Acta 2010; 1802: 396-405.
51. Shu Y, Zhang H, Kang T, Zhang JJ, Yang Y, Liu H et al. PI3K/Akt signal pathway involved in the cognitive impairment caused by chronic cerebral hypoperfusion in rats. PloS One 2013; 8: e81901.
52. Guan JL. Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol 1997; 29: 1085-1096.
53. Wojcik-Stanaszek L, Gregor A, Zalewska T. Regulation of neurogenesis by extracellular matrix and integrins. Acta Neurobiol Exp 2011; 71: 103-112.
54. Chambers RA. Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders. Drug Alcohol Depend 2013; 130: 1-12.
55. McAllister AK. Major histocompatibility complex I in brain development and schizophrenia. Biol Psychiatry 2014; 75: 262-268.
56. Sankar A, MacKenzie RN, Foster JA. Loss of class I MHC function alters behavior and stress reactivity. J Neuroimmunol 2012; 244: 8-15.
57. Crews FT. Immune function genes, genetics, and the neurobiology of addiction. Alcohol Res Curr Rev 2012; 34: 355-361.
58. Osorio J. MHC class II pathway mediates adipose inflammation. Nat Rev Endocrinol 2013; 9: 252.
59. Wang J, Sun S, Zhang L, Wang Z, Ye L, Liu L et al. Further study of genetic association between the TNXB locus and schizophrenia. Psychiatr Genet 2011; 21: 216.
60. Ouzir M. Impulsivity in schizophrenia: a comprehensive update. Aggress Violent Behav 2012; 18: 247-254.
61. Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry 1996; 153: 974-984.
62. Trainor BC, Kyomen HH, Marler CA. Estrogenic encounters: how interactions between aromatase and the environment modulate aggression. Front Neuroendocr 2006; 27: 170-179.
63. Lasky JL, Wu H. Notch signaling, brain development, and human disease. Pediatr Res 2005; 57: 104R-109RR.
64. Zhang C, Gao J, Zhang H, Sun L, Peng G. Robo2-slit and Dcc-netrin1 coordinate neuron axonal pathfinding within the embryonic axon tracts. J Neurosci 2012; 32: 12589-12602.
65. Grant A, Hoops D, Labelle-Dumais C, Prevost M, Rajabi H, Kolb B et al. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine. Eur J Neurosci 2007; 26: 3215-3228.
66. Manitt C, Eng C, Pokinko M, Ryan RT, Torres-Berrio A, Lopez JP et al. dcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients. Transl Psychiatry 2013; 3: e338.
67. Adasme T, Haeger P, Paula-Lima AC, Espinoza I, Casas-Alarcon MM, Carrasco MA et al. Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation. Proc Natl Acad Sci USA 2011; 108: 3029-3034.
68. Dabertrand F, Nelson MT, Brayden JE. Ryanodine receptors, calcium signaling, and regulation of vascular tone in the cerebral parenchymal microcirculation. Microcirculation. 2013; 20: 307-316.
69. Kurokawa K, Mizuno K, Kiyokage E, Shibasaki M, Toida K, Ohkuma S. Dopamine D1 receptor signaling system regulates ryanodine receptor expression after intermittent exposure to methamphetamine in primary cultures of midbrain and cerebral cortical neurons. J Neurochem 2011; 118: 773-783.
70. Quezada-Calvillo R, Robayo-Torres CC, Ao Z, Hamaker BR, Quaroni A, Brayer GD et al. Luminal substrate "brake" on mucosal maltase-glucoamylase activity regulates total rate of starch digestion to glucose. J Pediatr Gastroenterol Nutr 2007; 45: 32-43.
71. Terracciano A, Tanaka T, Sutin AR, Sanna S, Deiana B, Lai S et al. Genome-wide association scan of trait depression. Biol Psychiatry 2010; 68: 811-817.
72. Ino H. Immunohistochemical characterization of the orphan nuclear receptor ROR alpha in the mouse nervous system. J Histochem Cytochem 2004; 52: 311-323.
73. Lalonde R, Strazielle C. Discrimination learning in Rora(sg) and Grid2(ho) mutant mice. Neurobiol Learn Mem 2008; 90: 472-474.
74. de Quervain DJ, Kolassa IT, Ackermann S, Aerni A, Boesiger P, Demougin P et al. PKCalpha is genetically linked to memory capacity in healthy subjects and to risk for posttraumatic stress disorder in genocide survivors. Proc Natl Acad Sci USA 2012; 109: 8746-8751.
75. Rodd ZA, Kimpel MW, Edenberg HJ, Bell RL, Strother WN, McClintick JN et al. Differential gene expression in the nucleus accumbens with ethanol selfadministration in inbred alcohol-preferring rats. Pharmacol Biochem Behav 2008; 89: 481-498.
76. Melen E, Himes BE, Brehm JM, Boutaoui N, Klanderman BJ, Sylvia JS et al. Analyses of shared genetic factors between asthma and obesity in children. J Allergy Clin Immunol 2010; 126: 631-7 e1-8.
77. Jablensky A, Morar B, Wiltshire S, Carter K, Dragovic M, Badcock JC et al. Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia. Genes Brain Behav 2011; 10: 410-417.
78. Folsom TD, Fatemi SH. The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 2013; 68: 122-135.
79. Baune BT, Konrad C, Suslow T, Domschke K, Birosova E, Sehlmeyer C et al. The Reelin (RELN) gene is associated with executive function in healthy individuals. Neurobiol Learn Mem 2010; 94: 446-451.
80. Laviola G, Ognibene E, Romano E, Adriani W, Keller F. Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modelling of major neurobehavioral syndromes. Neurosci Biobehav Rev 2009; 33: 560-572.
81. Hasbi A, Fan T, Alijaniaram M, Nguyen T, Perreault ML, O'Dowd BF et al. Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci USA 2009; 106: 21377-21382.
82. Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H et al. Genomewide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry 2013; 76: 66-74.
83. Marambaud P, Dreses-Werringloer U, Vingtdeux V. Calcium signaling in neurodegeneration. Mol Neurodegen 2009; 4: 20.
84. Massey PV, Bashir ZI. Long-Term depression: multiple forms and implications for brain function. Trends Neurosci 2007; 30: 176-184.
85. Selemon LD. A role for synaptic plasticity in the adolescent development of executive function. Transl Psychiatry 2013; 3: e238.
86. Collingridge GL, Peineau S, Howland JG, Wang YT. Long-Term depression in the CNS. Nat Rev Neurosci 2010; 11: 459-473.
87. Bliss TV, Collingridge GL. A synaptic model of memory: long-Term potentiation in the hippocampus. Nature 1993; 361: 31-39.
88. Birnbaum SG, Yuan PX, Wang M, Vijayraghavan S, Bloom AK, Davis DJ et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004; 306: 882-884.
89. Pattij T, Vanderschuren LJ. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 2008; 29: 192-199.
90. Lucas-Meunier E, Fossier P, Baux G, Amar M. Cholinergic modulation of the cortical neuronal network. Pflugers Arch 2003; 446: 17-29.
91. Abreu-Villaca Y, Filgueiras CC, Manhaes AC. Developmental aspects of the cholinergic system. Behav Brain Res 2011; 221: 367-378.
92. Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M. Endogenous acetylcholine modulates impulsive action via alpha4beta2 nicotinic acetylcholine receptors in rats. Eur J Pharmacol 2010; 641: 148-153.
93. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 2010; 30: 2017-2024.
94. Wiskerke J, Stoop N, Schetters D, Schoffelmeer AN, Pattij T. Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice. PloS One 2011; 6: e25856.
95. Navarrete F, Perez-Ortiz JM, Manzanares J. Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice. Br J Pharmacol 2012; 165: 260-273.
96. Dinu IR, Popa S, Bicu M, Mota E, Mota M. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects. Rom J Intern Med 2009; 47: 9-18.
97. Bidwell LC, Metrik J, McGeary J, Palmer RH, Francazio S, Knopik VS. impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems. J Stud Alcohol Drugs 2013; 74: 867-878.
98. Grano N, Keltikangas-Jarvinen L, Kouvonen A, Puttonen S, Vahtera J, Elovainio M et al. Association of impulsivity with sleep duration and insomnia in an employee population. Pers Indiv Differ 2007; 43: 307-318.
99. Ciarleglio CM, Resuehr HE, McMahon DG. Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues. Neuroscience 2011; 197: 8-16.
100. Groth RD, Weick JP, Bradley KC, Luoma JI, Aravamudan B, Klug JR et al. D1 dopamine receptor activation of NFAT-mediated striatal gene expression. Eur J Neurosci 2008; 27: 31-42.